rs34236495

Variant summary

Our verdict is Benign. The variant received -18 ACMG points: 2P and 20B. PM1BP4_StrongBP6_Very_StrongBA1

The NM_000092.5(COL4A4):​c.2008G>A​(p.Val670Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0029 in 1,612,738 control chromosomes in the GnomAD database, including 114 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.015 ( 67 hom., cov: 32)
Exomes 𝑓: 0.0016 ( 47 hom. )

Consequence

COL4A4
NM_000092.5 missense

Scores

17

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:11

Conservation

PhyloP100: -0.0440

Publications

11 publications found
Variant links:
Genes affected
COL4A4 (HGNC:2206): (collagen type IV alpha 4 chain) This gene encodes one of the six subunits of type IV collagen, the major structural component of basement membranes. This particular collagen IV subunit, however, is only found in a subset of basement membranes. Like the other members of the type IV collagen gene family, this gene is organized in a head-to-head conformation with another type IV collagen gene so that each gene pair shares a common promoter. Mutations in this gene are associated with type II autosomal recessive Alport syndrome (hereditary glomerulonephropathy) and with familial benign hematuria (thin basement membrane disease). Two transcripts, differing only in their transcription start sites, have been identified for this gene and, as is common for collagen genes, multiple polyadenylation sites are found in the 3' UTR. [provided by RefSeq, Jul 2008]
COL4A4 Gene-Disease associations (from GenCC):
  • autosomal recessive Alport syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, G2P, Myriad Women’s Health, Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • Alport syndrome
    Inheritance: SD Classification: DEFINITIVE Submitted by: ClinGen
  • hematuria, benign familial, 1
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Genomics England PanelApp
  • autosomal dominant Alport syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -18 ACMG points.

PM1
In a hotspot region, there are 4 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 2 benign, 8 uncertain in NM_000092.5
BP4
Computational evidence support a benign effect (MetaRNN=0.0026720762).
BP6
Variant 2-227062578-C-T is Benign according to our data. Variant chr2-227062578-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 255018.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0504 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000092.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
COL4A4
NM_000092.5
MANE Select
c.2008G>Ap.Val670Ile
missense
Exon 26 of 48NP_000083.3P53420

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
COL4A4
ENST00000396625.5
TSL:5 MANE Select
c.2008G>Ap.Val670Ile
missense
Exon 26 of 48ENSP00000379866.3P53420

Frequencies

GnomAD3 genomes
AF:
0.0151
AC:
2287
AN:
151836
Hom.:
67
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0524
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00466
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.000280
Gnomad OTH
AF:
0.0154
GnomAD2 exomes
AF:
0.00390
AC:
972
AN:
249510
AF XY:
0.00297
show subpopulations
Gnomad AFR exome
AF:
0.0553
Gnomad AMR exome
AF:
0.00226
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000256
Gnomad OTH exome
AF:
0.00115
GnomAD4 exome
AF:
0.00164
AC:
2396
AN:
1460784
Hom.:
47
Cov.:
30
AF XY:
0.00143
AC XY:
1038
AN XY:
726780
show subpopulations
African (AFR)
AF:
0.0547
AC:
1829
AN:
33414
American (AMR)
AF:
0.00253
AC:
113
AN:
44716
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26124
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39692
South Asian (SAS)
AF:
0.0000580
AC:
5
AN:
86236
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53416
Middle Eastern (MID)
AF:
0.00225
AC:
13
AN:
5768
European-Non Finnish (NFE)
AF:
0.000221
AC:
245
AN:
1111048
Other (OTH)
AF:
0.00315
AC:
190
AN:
60370
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.471
Heterozygous variant carriers
0
108
216
323
431
539
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
64
128
192
256
320
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0151
AC:
2288
AN:
151954
Hom.:
67
Cov.:
32
AF XY:
0.0142
AC XY:
1054
AN XY:
74274
show subpopulations
African (AFR)
AF:
0.0523
AC:
2165
AN:
41432
American (AMR)
AF:
0.00465
AC:
71
AN:
15262
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5172
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4818
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10524
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.000280
AC:
19
AN:
67962
Other (OTH)
AF:
0.0152
AC:
32
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
106
212
319
425
531
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
24
48
72
96
120
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00609
Hom.:
50
Bravo
AF:
0.0174
ESP6500AA
AF:
0.0492
AC:
185
ESP6500EA
AF:
0.000488
AC:
4
ExAC
AF:
0.00468
AC:
565
Asia WGS
AF:
0.00231
AC:
8
AN:
3478
EpiCase
AF:
0.000327
EpiControl
AF:
0.000237

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
4
not specified (4)
-
-
3
not provided (3)
-
-
2
Alport syndrome (2)
-
-
1
Benign familial hematuria;C4746745:Autosomal recessive Alport syndrome (1)
-
-
1
Focal segmental glomerulosclerosis (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.070
BayesDel_addAF
Benign
-0.46
T
BayesDel_noAF
Benign
-0.40
CADD
Benign
5.7
DANN
Benign
0.94
DEOGEN2
Benign
0.066
T
Eigen
Benign
-1.1
Eigen_PC
Benign
-1.0
FATHMM_MKL
Benign
0.023
N
LIST_S2
Benign
0.60
T
MetaRNN
Benign
0.0027
T
MetaSVM
Benign
-0.78
T
MutationAssessor
Benign
0.17
N
PhyloP100
-0.044
PrimateAI
Benign
0.34
T
PROVEAN
Benign
-0.010
N
REVEL
Benign
0.075
Sift
Benign
1.0
T
Sift4G
Benign
0.70
T
Polyphen
0.017
B
Vest4
0.15
MVP
0.56
MPC
0.27
ClinPred
0.0024
T
GERP RS
0.61
Varity_R
0.032
gMVP
0.12
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs34236495; hg19: chr2-227927294; COSMIC: COSV61631610; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.